IR-MED Appoints Healthcare Executive and Entrepreneur Tzur Di-Cori as Chief Executive Officer
04. Oktober 2023 16:05 ET
|
IR-Med, Inc.
Mr. Di-Cori’s vast healthcare experience includes President of LifeWatch Technologies, a developer of technologies that help physicians detect symptoms before they become major health problems Rosh...
IR-MED to Conduct Usability Study with Methodist Healthcare of San Antonio for its PressureSafe Device Which is Slated for U.S. Launch in H1 2024
26. September 2023 09:00 ET
|
IR-Med, Inc.
Study to address the substantial challenge of healthcare inequality in the early detection of pressure injuries in people of dark skin tonesPressureSafe, a skin-color agnostic decision support device,...
IR-MED Appoints Richard Serbin, Esq. to its Advisory Board
13. September 2023 09:15 ET
|
IR-Med, Inc.
Served as Chief FDA Counsel for Revlon and Johnson & Johnson, as a Board Member at Johnson & Johnson Development Corporation, that company’s strategic venture capital division, and as patent...
IR-MED Chairman & Interim CEO Issues Letter to Shareholders
21. August 2023 09:15 ET
|
IR-Med, Inc.
Rosh Pina, Israel, Aug. 21, 2023 (GLOBE NEWSWIRE) -- IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive AI-driven infrared spectrographic analysis technology platform...
IR-MED’s AI-Powered Infra-Red Spectrographic Decision Support System PressureSafe Device Demonstrates High Efficacy in Detecting Pressure Injuries with 96% Accuracy: Potential to Set a New Standard of Care
17. Juli 2023 09:15 ET
|
IR-Med, Inc.
IR-MED to file for FDA approval Q4 2023 with U.S. market launch expected in H1 20242.5 million patients develop pressure injuries and 60,000 die annually as a direct result; $26.8 billion is spent...
IR-MED Honors Juneteenth with Commitment to Healthcare Equality: PressureSafe Device Sees Beneath the Skin to Address Inequality in Pressure Injuries
12. Juni 2023 09:15 ET
|
IR-Med, Inc.
Early detection of pressure injuries can be challenging for minority populations due to the current method of visual inspectionPatients with dark skin tones suffered more than twice as much as those...
IR-Med Appoints Dr. Lynn Eschenbacher to its Advisory Board as Company Advances Toward Launch of its PressureSafe Wound Care Device
07. Juni 2023 09:28 ET
|
IR-Med, Inc.
Innovative executive driving positive outcomes and profitability, Dr. Eschenbacher is focused on addressing healthcare access and equityThrough early, non-invasive detection of pressure injuries,...
IR-Med’s PressureSafe Noninvasive Wound Care Device to be Demonstrated at Northwell Health’s 10th Annual Shining the Light on Wound Care Symposium
19. Mai 2023 09:15 ET
|
IR-Med, Inc.
A 94.7% accuracy in identifying Stage 1 pressure injuries was achieved in a proof-of-concept device upon which PressureSafe is basedCompany to exhibit and demo its “sense the invisible” handheld...
IR-Med to present at National Pressure Injury Advisory Panel 2023
14. März 2023 09:00 ET
|
IR-Med, Inc.
The company’s PressureSafe device is being designed to reduce healthcare disparity in pressure injury detection and treatment Rosh Pina, Israel, March 14, 2023 (GLOBE NEWSWIRE) -- “IR-MED” or the...
IR-MED SIGNS AGREEMENT TO EXPAND ITS PRESSURESAFE DEVICE USABILITY STUDY
14. Februar 2023 09:15 ET
|
IR-Med, Inc.
The study will expand to Rabin Medical Center (RMC), in parallel to Beit-Rivka, turning the study to a double center usability study. Rosh Pinna, Israel, Feb. 14, 2023 (GLOBE NEWSWIRE) --...